SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-027059
Filing Date
2023-06-08
Accepted
2023-06-08 17:02:14
Documents
13
Period of Report
2023-06-02
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axsm-20230602.htm   iXBRL 8-K 123465
2 EX-10.1 axsm-ex10_1.htm EX-10.1 109424
  Complete submission text file 0000950170-23-027059.txt   365087

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axsm-20230602.xsd EX-101.SCH 2451
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axsm-20230602_lab.xml EX-101.LAB 12806
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axsm-20230602_pre.xml EX-101.PRE 9441
7 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20230602_htm.xml XML 4543
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 231002765
SIC: 2834 Pharmaceutical Preparations